Low concentrations of nitric oxide delay the differentiation of embryonic stem cells and promote their survival by Martín, F. et al.
Low concentrations of nitric oxide delay the
differentiation of embryonic stem cells and promote
their survival
JR Tejedo*,1, R Tapia-Limonchi2, S Mora-Castilla1, GM Cahuana1, A Hmadcha2, F Martin1, FJ Bedoya1 and B Soria2
Nitric oxide (NO) is an intracellular messenger in several cell systems, but its contribution to embryonic stem cell (ESC) biology
has not been characterized. Exposure of ESCs to low concentrations (2–20 lM) of the NO donor diethylenetriamine NO adduct
confers protection from apoptosis elicited by leukaemia inhibitory factor (LIF) withdrawal. NO blocked caspase 3 activation,
PARP degradation, downregulation of the pro-apoptotic genes Casp7, Casp9, Bax and Bak1 and upregulation of the anti-
apoptotic genes Bcl-2 111, Bcl-2 and Birc6. These effects were also observed in cells overexpressing eNOS. Exposure of
LIF-deprived mESCs to low NO prevented the loss of expression of self-renewal genes (Oct4, Nanog and Sox2) and the SSEA
marker. Moreover, NO blocked the differentiation process promoted by the absence of LIF and bFGF in mouse and human
ESCs. NO treatment decreased the expression of differentiation markers, such as Brachyury, Gata6 and Gata4. Constitutive
overexpression of eNOS in cells exposed to LIF deprivation maintained the expression of self-renewal markers, whereas the
differentiation genes were repressed. These effects were reversed by addition of the NOS inhibitor L-NMMA. Altogether, the data
suggest that low NO has a role in the regulation of ESC differentiation by delaying the entry into differentiation, arresting the loss
of self-renewal markers and promoting cell survival by inhibiting apoptosis.
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Embryonic stem cells (ESCs) retain their ability to self-renew
and to differentiate into a great variety of cell types. The genes
Oct4, Sox2, Nanog and Myc are key regulators essential for
the maintenance of self-renewal.1 The differentiation of ESCs
is accompanied by the downregulation of these transcription
factors and upregulation of transcription factors involved in
differentiation.2 Loss of Oct4 causes inappropriate differentia-
tion of ESCs into trophectoderm, whereas overexpression of
Oct4 results in differentiation into primitive endoderm and
mesoderm.3 Nanog regulates pluripotency mainly as a
transcriptional repressor of downstream genes that are
important for cell differentiation, such as Gata4 and Gata6.4
These factors form a tight transcriptional regulatory circuit that
maintains ESCs in an undifferentiated state.
In addition, these transcription factors are switched on and
off by external signals.5 Thus, leukaemia inhibitory factor (LIF)
maintains the self-renewal state in mESCs through activation
of the JAK/STAT pathway.6 The main downstream target of
the LIF is c-myc, an early response gene that promotes the
expression of the regulatory subunit of telomerase.7 LIF also
activates c-Src tyrosine kinase, extracellular signal-regulated
kinases (ERKs) and the phosphoinositide 3-kinase, which
is relevant for the proliferation and survival of mESCs.8
However, LIF signalling is not sufficient to sustain self-
renewal, and additional signals are required to repress
differentiation.9 It has been shown that IRS-1 expression is
necessary for maintaining the self-renewal state in mESCs,
and that this action is independent of Stat3 phosphorylation.10
Also, expression of the active form of Akt is sufficient to
maintain the undifferentiated phenotype of these cells.11
These reports suggest that the phosphoinositide 3-kinase/Akt
pathway is necessary for the maintenance of self-renewal in
mESCs.
In hESCs, themaintenance of undifferentiated growth is LIF
independent. In this regard, hESCs grown in feeder layer-free
culture require a medium conditioned by fibroblast culture.
In the absence of such conditioned medium, high concentra-
tions of basic fibroblast growth factor (bFGF) and Noggin are
necessary to maintain self-renewal.12 In fact, activation of the
FGF pathway is necessary for the control of survival and
proliferation in several cell types.13 Increases in MAP-Erk
kinase/ERK and Akt phosphorylation downstream of bFGF
have been reported to occur in hESCs.14 Moreover, bFGF can
function in cooperation with insulin-like growth factor II to
maintain hESC pluripotency. Although bFGF contributes to
cell survival with little influence on apoptosis, insulin-like
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growth factor-II increases proliferation and prevents apopto-
sis.15 Other signal transduction pathways that have a role in
hESC self-renewal include the transforming growth factor-b
(TGF-b)/Activin/Nodal,16,17 phosphoinositide 3-kinase18 and
Wnt19 pathways.
Nitric oxide (NO) is a signalling molecule that regulates cell
survival and proliferation in diverse cell types.20,21 It has also
been shown to affect gene expression at the level of
transcription and translation.22 NO is produced during the
development of organisms by isoforms of NO Synthases
(NOSs), and it is feasible that it might contribute to the
regulation of some features of ESC biology. It has been
reported that at physiological concentrations, NO functions as
a negative regulator of stem/progenitor cell proliferation, and
it is critical for the initiation of differentiation.23 A distinct
feature NO is that actions inside cells depend heavily on its
concentration. In the micromolar or nanomolar range, activa-
tion of survival and of the guanylate cyclase/protein kinase G
system has been reported.24 Homeostatic concentrations of
NO (1–10 mM) can initiate signalling pathways implicated in
survival actions in RINm5F cells and promote the activation of
c-Src, which at the same time induces the activation of IRS-1,
phosphoinositide 3-kinase, AKT and eNOS as a part of the
survival response.21 Moreover, the generation of NO partici-
pates in the activation of survival pathways by insulin-like
growth factor-1 and insulin in b-cells.25 Thus, many of the
signalling pathways activated by NO in other cell systems are
operative in ESCs. Recent reports have shown that a
functional NO-cGMP signalling system might be involved in
early differentiation events of ESCs.26 However, it has also
been proposed that the dual role of NO in the control of ESC
differentiation might depend on the expression of NO-signalling
components rather than on the differential expression of NOS
isoforms during this period of development.24,26
Great effort is being devoted to identifying strategies that
improve the self-renewal and pluripotency of ESCs. Here, we
provide evidence for a role of NO in delaying ESC differentia-
tion. This effect is independent of LIF, suggesting that this
messenger could be used to improve ESC self-renewal in
culture.
Results
Differential expression of NO synthases and expression
of self-renewal markers in mESCs. NOS isoforms gene
expression analysis of D3-mESCs transfected with a construct
containing the eGFP gene under control of the Oct4 promoter
(D3-pOct4-eGFP-mESCs) and selected by sorting revealed
that cells cultured in the presence of LIF expressed the eNOS.
Differentiation of these cells following LIF withdrawal or as
embryoid bodies led to a substantial decrease of eNOS and
an increase in the expression of the iNOS isoform. Further,
nNOS expression remained unchanged except for a slight
increase in cells differentiated as embryoid bodies (Figure 1a).
A time course study revealed that eNOS expression levels
decreased significantly from the second day of LIF withdrawal;
the lowest levels were observed between 4 and 7 days
(Figure 1b upper), whereas iNOS expression began on day 5
and peaked on day 7 (Figure 1b lower).
Next, D3-pOct4-eGFP-mESCs were transfected with a
vector that constitutively overexpresses the eNOS gene
under control of the CMV promoter (D3-pOct4-eGFP-eNOS-
mESC). Both green mESCs were selected by sorting in
control conditions (Figure 1c and, Supplementary Figure 1).
These cells expressed Nanog, Oct4 and Sox2 more highly
than did wild-type D3-mESCs. In addition, showed high levels
of Tert (Figure 1c), telomerase activity (Figure 1d) and eNOS
protein (Figure 1e) relative to D3-mESCs. Furthermore,
colonies of these cells emit green fluorescence, as confirmed
by fluorescence microscopy and flow cytometry (Supplemen-
tary Figure 1a and b).
Effect of NO on apoptosis induced by LIF withdrawal in
mESCs. In D3-pOct4-eGFP-mESCs we studied the effect
of low concentrations of the diethylenetriamine nitric oxide
adduct (DETA-NO) on cell survival and apoptosis. LIF
deprivation led to a 6.5-fold increase in DNA fragmenta-
tion (Figure 2a, shaded bars); the exposure to 2–10 mM
DETA-NO conferred protection against this action. DETA-NO
concentrations of 20 mM or higher induced a significant
increase in apoptosis (3.5-fold at 20 mM and eight-fold at
50 mM) in comparison to LIF control cells. Cells grown in
the presence of LIF, a significant effect of DETA-NO on
DNA fragmentation was observed at 50 mM, the highest
concentration tested (Figure 2a, open bars). Next, we
tested the effect of endogenously NO on cell survival by
using D3-mESC-Oct4-eGFP-eNOS-mESCs (Figure 2b).
A significant decrease in DNA fragmentation was observed
in these cells when compared with D3 and D3-pOct4-eGFP-
mESCs cultured in the absence of LIF for 7 days.
Overexpression of eNOS, however, did not completely
prevent the apoptosis induced by LIF withdrawal. To
identify the mechanism involved in the protective action of
NO, we studied the expression of apoptotic genes in these
cells (Figure 2c). D3-pOct4-eGFP-mESCs grown in the
absence of LIF and in the presence of 2 mM DETA-NO
showed a decrease in the expression of pro-apoptotic
genes, such as Bax, Bak1, Casp9 and Casp7. The
expression levels of the anti-apoptotic genes Bcl2l11, Bcl2
and Birc6 were two-fold higher than the levels in cells
cultured under LIF withdrawal conditions (Figure 2c).
Moreover, PARP downregulation and caspase 3 activation
induced by LIF withdrawal were inhibited by NO treatment
(Figure 2d). In addition, R1-mESCs cultured in the absence
of LIF and in the presence of 2mM DETA-NO displayed
a distinct morphology when compared with cells cultured
in the absence of LIF, some of them showing a compact
morphology with well-defined borders typical of the
‘stemness’ state (Supplementary Figure 3).
Impact of NO on the regulation of pluripotency and
differentiation markers in mESCs. A dose-dependency
of DETA-NO was carried out to study the effect of NO on
the pluripotency markers Oct4 and Nanog. Figure 3a shows
that Oct4 expression was not affected by exposing cells
to DETA-NO (2–50 mM) in the presence of LIF, whereas
Nanog expression was enhanced. Oct4 and Nanog expres-
sion decreased when cells were incubated with 50 mM
DETA-NO (Figure 3a). In mESCs cultured in the absence
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of LIF, DETA-NO (2–50mM) promoted both Oct4 and Nanog
protein expression (Figure 3a).
Using R1-E-mESCs we studied the effect of NO in other
mESC line. R1-E-mESCs cultured in the presence of LIF grew
in colonies displaying stronger positive staining for alkaline
phosphatase (100%) than cells grown in the absence of LIF
(14%). Supplementation of 2mMDETA-NO tomediumwithout
LIF partially restored alkaline phosphatase activity (40%); the
number of positive colonies decreased as the concentration of
DETA-NO increased: 5 mM (36%), 10 mM (25%), 20 mM (20%)
and 50 mM (9.5%) (Figure 3c). In addition, the expression of
differentiation markers was analyzed by quantitative real time
(qRT)-PCR. Early differentiation genes, such as Brachyury,
Gata4, Gata6, Fgf5 and Fgf8 are expressed in cells cultured
in the absence of LIF. DETA-NO supplementation led to
lower expression of these genes (Figure 3b). The levels of
expression observed with 2 mM DETA-NO were comparable
to those obtained in cells grown in the presence of LIF.
Moreover, as the concentration of NO increased, the
expression of differentiation markers also increased
(Figure 3b).
NO delays mESC differentiation. We next investigated
the effect of exogenous NO on differentiation. In D3-pOct4-
eGFP-mESCs, the exposure to LIF led to the expression of
GFP in 69.7±8.5% of cells. However, when cells were
cultured in the absence of LIF, the percentage of GFP-
positive cells decreased (27.7±5.5%). Supplementation with
2 mM DETA-NO increased the percentage of GFP-positive
cells (45.4±6.5%) (Figure 4a).
In addition, mESCs cultured in the absence of LIF
supplemented with 2 mM DETA-NO showed significantly
higher expression of Oct4, Sox2 and Nanog than cells
cultured in the absence of LIF (Figure 4b). Western blot
Figure 1 Differential expression of nitric oxide (NO) synthases and expression of self-renewal markers in mESCs. (a) NO synthase expression during differentiation.
Sorted D3-pOct4-eGFP mESCs were cultured for 7 days in the presence or absence of LIF attached to a surface and for 14 days by hanging drop protocol (EB preparation).
eNOS, iNOS and nNOS expression were detected by RT-PCR. The images are representative of three experiments. (b) Time course of eNOS and iNOS expression. R1-E
mESCs were cultured in the absence of LIF for 7 days. eNOS and iNOS expression were detected by qRT-PCR, b-actin was used as an endogenous control and cycle
threshold (Ct) values were normalized with respect to those of cells cultured in the presence of LIF (day 0). Data shown are from three independent experiments. *Pr0.005
with respect to day 0. (c) qRT-PCR of undifferentiation markers. D3 mESCs, D3-pOct4-eGFP mESCs and D3-pOct4-eGFP-eNOS mESCs were cultured in the presence of LIF
and gene expression was determined by qRT-PCR. Data are the mean±S.E.M. of three experiments; *Pr0.005 when compared with D3 cells and **Pr0.005 when
compared with D3-pOct4-eGFP cells. (d) Telomerase activity in D3 mESCs, D3-pOct4-eGFP mESCs and D3-pOct4-eGFP-eNOS mESCs. Each data point represent the
mean± S.E.M. of three experiments; *Pr0.005 when compared with other cell types. (e) Western blot analysis of eNOS in D3 mESCs, D3-pOct4-eGFP mESCs and D3-
pOct4-eGFP-eNOS mESCs. Representative image of three independent experiments
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analysis also showed higher levels of these proteins, but with
Sox2 and Nanog in a different pattern than the gene
expression. It is of note that the levels of the proteins shown
were similar to those found in undifferentiated cells
(Figure 4c). In non-transfected D3-mESCs, the expression
of Brachyury (Figure 4d) increased by LIF-withdrawal was
cancelled by 2 mMDETA-NO. In addition, the co-expression of
SSEA-1 and Oct4 protein (Figure 4e and Supplementary
Figure 2A) decreased in the absence of LIF, whereas
simultaneous treatment with DETA-NO maintained the Oct
4 and SSEA-1 signals. To address the effect of NO on
apoptosis and pluripotency/differentiation, we monitored
caspase 3 activation and Nanog and Brachyury expression
in the presence of DETA-NO and staurosporine, an inducer of
apoptosis (Supplementary Figure 2C). Staurosporine cancels
the protective effect of NO on apoptosis induced by LIF
withdrawal without affecting the effect of NO on Nanog or
Brachyury expression.
Endogenous eNOS overexpression maintains mESCs in
an undifferentiated state. A second approach was to study
the effect of endogenous NO production by eNOS over-
expression using D3-pOct4-eGFP-eNOS-mESCs. Growth in
the presence of LIF resulted in 70.9±3.1% GFP-positive
cells. In the absence of LIF, the proportion of GFP-positive
cells decreased to 51.8±9.1%. The proportion of GFP-
positive cells dropped to 16.4±5.8% when NOS activity was
inhibited with 400mM L-NMMA (Figure 5a).
qRT-PCR revealed that the expression of pluripotency
markers was lower in D3-pOct4-eGFP-eNOS-mESCs cul-
tured in the absence of LIF in comparison with those grown
in its presence, but their expression decreased when
NOS activity was inhibited with 400mM L-NMMA (Figure 5b).
A similar effect was observed in western blot analysis
(Figure 5c). The protein levels of Oct4 decreased signi-
ficantly, whereas Sox2 also decreased, but this change
was not significant. It is of note that the levels of Nanog
did not change significantly between the two conditions
(Figure 5c). In contrast, when NOS activity was inhibited,
the expression of the Brachyury gene increased with respect
to its expression in cells cultured with LIF (Figure 5d). The
co-expression of SSEA-1 and Oct4 protein decreased in
the absence of LIF, and it was completely inhibited when
NO production was blocked with 400mM L-NMMA (Figure 5e
and Supplementary Figure 2B). In the presence of LIF,
L-NMMA partially reduced Oct4 expression both in wild-type
mESCs and mESCs overexpressing eNOS (Supplementary
Figure 2D).
Figure 2 Effect of different NO concentrations on apoptosis and cell survival. (a) Effect of DETA-NO on DNA fragmentation. D3-pOct4-eGFP mESCs were cultured for
7 days in the presence or absence of LIF treated with different concentrations (2–50mM) of DETA-NO. DNA fragmentation was measured. Data are the mean±S.E.M. of five
independent experiments. *Pr0.005 versus. D3 mESCs cultured in the presence of LIF and in the absence of DETA-NO (b) D3, D3-pOct4-eGFP and D3-pOct4-eGFP-eNOS
mESCs were cultured in the presence or absence of LIF for 7 days and DNA fragmentation was measured. Data are the mean± S.E.M. of five independent experiments.
*Pr0.005 versus. D3 and D3-pOct4-eGFP mESCs cultured in the absence of LIF. **Pr0.005 versus. mESCs cultured in the presence of LIF. (c) Analysis of pro-apoptotic
and anti-apoptotic gene expression in D3-pOct4-eGFP mESCs. Cells were cultured in the absence of LIF and treated with 2 mM DETA-NO gene expression was determined
by qRT-PCR. b-actin was used as an endogenous control and Ct values were normalized with respect to the Ct of cells cultured in absence of LIF. Data are the
mean± S.E.M. of three experiments. (d) Effect of DETA-NO on PARP and caspase 3 cleavage. D3-pOct4-eGFP mESCs were cultured in the presence or absence of LIF
for 7 days and supplemented with 2 mM DETA-NO. PARP and cleaved caspase 3 were detected by western blot. The positive control for apoptosis was 1mM Staurosporine.
Figures are representative of three independent experiments
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Low amounts of NO maintain hESC pluripotency. In the
hESC HS181 line, the presence of 8 ng/ml bFGF maintained
the undifferentiated features of colonies for up to five
passages (Figure 6a, upper row, left picture). After five
passages in the absence of bFGF, the colonies displayed
white areas, which are typical of the differentiated state
(Figure 5a, upper row, middle picture). When cells were
cultured in bFGF-deprived conditions supplemented with
2mM DETA-NO for up to five passages, undifferentiated
characteristics were restored and sub-culturing was possible
for 10 passages (Figure 5a, upper row, right picture). In
hESC colonies cultured for five passages, DETA-NO was
observed to increase Oct4 expression, which was much
greater than that noted under bFGF conditions (Figure 5a,
bottom row). Quantitative gene expression values were
obtained for pluripotency markers and differentiation genes
in hESCs. The expression of Nanog, Oct4 and Sox2
considerably declined in cells cultured in the absence of
bFGF; in contrast, cells treated with DETA-NO maintained
higher levels of these mRNAs, yet still lower than cells
cultured with bFGF (Figure 6b). These results were
confirmed by western blotting (Figure 6c). By contrast,
differentiation genes, such as Brachyury and Gata-4
showed a significant increase in expression in the absence
of bFGF that was cancelled by addition of DETA-NO
(Figure 6d). Next, we examined the expression of the cell-
surface antigen SSEA-4. The results showed that SSEA-4
expression disappeared after five passages of bFGF
withdrawal, but was present when the culture medium was
supplemented with 2 mM DETA-NO (Figure 6e).
Discussion
Evidence gathered in recent years indicates that NO
participates in the regulation of cell differentiation and tissue
morphogenesis,23,27 but its contribution to the control of ESC
Figure 3 Dose-dependent influence of DETA-NO on pluripotency and differentiation in mESCs. (a) Western blot analysis of Nanog and Oct4 in non-transfected D3
mESCs cultured in the absence or presence of LIF and supplemented with different DETA-NO concentrations (2–50mM) over 7 days. The image is representative of five
experiments. (b) Dose-dependent effect of DETA-NO on the expression of differentiation markers in R1-E mESCs cultured for 5 days; b-actin was used as the endogenous
control and Ct values were normalized with respect to the Ct of cells cultured in absence of LIF. Data are the mean± S.E.M. of five independent experiments. *Pr0.005
versus. cells cultured in the absence of LIF. **Pr0.005 versus. cells cultured in the absence of LIF supplemented with 2 mM DETA-NO. (c) Alkaline phosphatase activity
retained by cells treated with different concentrations of DETA-NO. Percentages were obtained with respect to the number of colonies in the culture in presence of LIF. Scale
bars, 20mM. Figures are representative of three independent experiments. Percentage data are the mean±S.E.M. of three independent experiments. *Pr0.005 when
compared with cells cultured in the absence of LIF
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biology remained to be substantiated. Here, we show that
low amounts of NO generated either from chemical donors
or following eNOS overexpression regulate apoptosis, self-
renewal and differentiation of ESC. When mESCs were
cultured under optimal conditions in the presence of LIF, high
expression levels of eNOS and slightly lower levels of nNOS
were detected. A specific decrease in the eNOS isoform was
apparent when cells were exposed to one of two differentia-
tion protocols, together with high expression of iNOS. The
high expression of iNOS indicates that high levels of NO
during sequential differentiation complement the effects
induced by LIF withdrawal. High NO was previously shown
to increase ESC differentiation towards definitive endoderm,
cardiomyocytes and neurons.28–30
LIF deprivation induces also differential expression of
NOS isoforms. eNOS expression significantly decreased
after LIF withdrawal until day 6, after which it maintained a
low expression level, whereas iNOS expression began to
increase after day 5 and was highest at day 7. The level of
expression of eNOS is associated to pluripotency as wild-type
Figure 4 Exogenous NO arrests the differentiation induced by LIF withdrawal in mESCs. (a) D3-pOct4-eGFP mESCs from passage 10 after sorting were cultured for
7 days in the presence (left panel) or absence (medium panel) of LIF and in the absence of LIF plus 2 mM DETA-NO (right panel). GFP intensity was measured by flow
cytometry. Cells with fluorescence intensity similar or higher than that observed for mESCs transfected with the pOct4-eGFP construct and cultured for 7 days in the presence
of LIF were considered positive for eGFP (M1 population). Each graph is representative of five independent experiments (n¼ 5). (b) qRT-PCR analysis of Oct4, Sox-2 and
Nanog in D3-pOct4-eGFP mESCs cultured for 7 days under the indicated conditions. b-actin was used as the endogenous control and Ct values were normalized with respect
to the Ct of cells cultured in the absence of LIF. Data are the mean±S.E.M. of three experiments. *Pr0.005 versus. cells cultured in the absence of LIF. (c) Western blot
analysis of Oct4, Sox-2 and Nanog in D3-pOct4-eGFP mESCs cultured for 7 days under the indicated conditions. Representative images and densitometry quantification are
from five independent experiments. (d) qRT-PCR analysis of Brachyury expression in D3-pOct4-eGFP mESCs. b-actin was used as the endogenous control and Ct values
were normalized with respect to the Ct of cells cultured in the absence of LIF. Data are the mean± S.E.M. of three experiments. *Pr0.005 versus. cells cultured in the
absence of LIF. (e) Confocal images of cells positive for SSEA-1 in non-transfected D3 mESCs cultured for 7 days in the presence (left panel) or absence (middle panel) of LIF
or in the absence of LIF plus 2 mM DETA-NO (right panel). Nuclei are counter-stained with DAPI. Images are from three independent experiments. Scale bars are 20mm
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D3-mESCs from passage 30 expressed lowed levels of
eNOS, and low expression of Oct4, Nanog, Sox2, Tert and
low telomerase activity. On the other hand sorted D3-pOct4-
eGFP-mESCs had increased levels of eNOS when compared
with D3 wild-type cells and also had increased levels of Oct4,
Nanog, Sox2, Tert and telomerase activity and eNOS over-
expression significantly increased the expression of Oct4,
Sox2, Tert and telomerase activity relative to D3-pOct4-
eGFP-mESCs. Furthermore, when eNOS activity was
blocked, undifferentiation markers decreased notably. These
findings support the notion that generation of low and
sustained levels of NO might be instrumental for the
maintenance of pluripotency. The hypothesis that precise
cellular responses are differentially regulated by specific NO
concentrations was previously proposed.31
Concentrations in the range 1–10 mM of DETA-NO and
endogenous NO generation by eNOS overexpression are
also capable of halting apoptosis induced by LIF starvation.
Figure 5 Endogenous production of NO by eNOS overexpression maintains mESC self-renewal after LIF withdrawal. (a) D3-pOct4-eGFP-eNOS mESCs from passage
10 after sorting were cultured for 7 days in the presence (left panel) or absence (medium panel) of LIF or in the absence of LIF plus 400mM L-NMMA (right panel). GFP intensity
was measured by flow cytometry. Cells with fluorescence intensity similar or higher than that observed for mESCs transfected with the pOct4-eGFP construct and cultured for
7 days in the presence of LIF were considered positive for eGFP (M1 population). Each graph is representative of five independent experiments (n¼ 5). (b) qRT-PCR analysis
of Oct4, Sox-2 and Nanog in D3-pOct4-eGFP-eNOS mESCs cultured for 7 days under the indicated conditions. b-actin was used as the endogenous control and Ct values
were normalized with respect to the Ct of cells cultured in the presence of LIF. Data are the mean±S.E.M. of three experiments. *Pr0.005 versus. cells cultured in the
absence of LIF. (c) Western blot analysis of Oct4, Sox-2 and Nanog in D3-pOct4-eGFP mESCs cultured for 7 days under the indicated conditions. Representative images and
densitometry quantification are from five independent experiments (d) qRT-PCR analysis of Brachyury expression in D3-pOct4-eGFP-eNOS mESCs. b-actin was used as the
endogenous control and Ct values were normalized with respect to the Ct of cells cultured in the absence of LIF. Data are the mean± S.E.M. of three experiments. *Pr0.005
versus cells cultured in the presence of LIF. (e) Immunofluorescence images of cells positive for SSEA-1 in D3-pOct4-eGFP-eNOS mESCs cultured for 7 days in the presence
(left panel) or absence (medium panel) of LIF or in the absence of LIF plus 400mM L-NMMA (right panel). Nuclei were counter-stained with DAPI. Images are representative of
three independent experiments. Scale bars are 20 mm
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Furthermore, treatment of mESCs with NO negatively
regulates the pro-apoptotic response and notably increases
the anti-apoptotic response. These results are consistent with
previous reports in other cell models in which it was shown
that NO prevented apoptosis by regulating Bcl2 family
proteins.32 In addition, mESCs overexpressing Bcl2 maintain
the characteristics of undifferentiated, pluripotent ESCs
during long-term culturing and maintain their potential to
differentiate into mature cell types.33 All these data are in
agreement with other results describing the anti-apoptotic and
survival effects of NO.20,21,25 A role for survival processes in
the maintenance of the undifferentiated state in ESCs is also
supported by several other studies.8,11,14,15,18 In addition,
using staurosporine, an inducer of apoptosis, together with
Figure 6 Exogenous NO arrests the differentiation induced by bFGF withdrawal in hESCs cultured in a feeder-free system. (a) Upper panel: Representative phase
contrast images showing the morphology of hESCs cultured for five passages in the presence (left) or the absence (middle) of bFGF and in the absence of bFGF plus 2mM
DETA-NO (right). Images are representative of 10 experiments. Lower panel: immunofluorescence images of cells positive for Oct4 in hESCs cultured for five passages in the
presence (left) or absence (middle) of bFGF or in the absence of bFGF plus 2 mM DETA-NO (right). Images are representative of three experiments. Scale bars are 20mm.
(b) qRT-PCR analyses of Oct4, Sox-2 and Nanog in H181 hESCs cultured for 10 days under the indicated conditions. b-actin was used as the endogenous control and
Ct values were normalized with respect to the Ct of cells cultured in the presence of bFGF. Data are the mean± S.E.M. of three experiments. *Pr0.005 versus cells cultured
in the absence of bFGF. **Pr0.005 versus cells cultured in the presence of LIF. (c) Western blot analysis of Oct4, Sox-2 and Nanog in H181 hESCs cultured for 10 days
under the indicated conditions. Representative images and densitometry quantifications are from five independent experiments. (d) qRT-PCR analysis of Brachyury and Gata4
expression in H181 hESCs . b-actin was used as the endogenous control and Ct values were normalized with respect to the Ct of cells cultured in the absence of bFGF. Data
are the mean± S.E.M. of three experiments. *Pr0.005 versus cells cultured in the absence of bFGF. (e) Confocal images of cells positive for SSEA-4 in hESCs cultured for
five passages in the presence (left panel) or absence (middle panel) of bFGF or in the absence of bFGF plus 2 mM DETA-NO (right panel). Nuclei were counter-stained with
DAPI. Images are representative of three experiments. Scale bars are 20 mm
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DETA-NO, we showed that staurosporine cancels NO effect
on caspase 3 activation induced by LIFwithdrawal. In contrast,
the effect of NO on Nanog and Brachyury levels was not
altered. These results suggest that NO protective action is
independent of its effect on pluripotency and differentiation.
The data presented in this report also provide evidence for a
role for NO in ESC pluripotency. In the absence of LIF, a low
level of DETA-NO maintains the self-renewal program in
some colonies by enhancing the expression of self-renewal
markers and increasing alkaline phosphatase activity. In
addititon, both mESCs and hESCs cultured in the absence
of LIF or bFGF and in the presence of NO, are capable of
forming teratomas in immunosuppressed mice (Supple-
mentary Figure 4). Previous reports have indicated a
requirement for Nanog up-regulation for the maintenance of
self-renewal.1,4,9,34 Masui et al.35 found that Sox2 controls the
transcriptional activation of Oct4. In fact, it has been recently
demonstrated that Oct4 expression is directly related to Sox2
expression.35,36 In accordance with these observations, our
study showed that Oct4, Nanog and Sox2 expression levels
are markedly increased by the addition of NO. Moreover,
when eNOS activity is blocked, Sox2 expression decreases.
One possibility is that NO could be controlling self-renewal
and pluripotency by modulating Oct4 expression by increas-
ing Sox2. Furthermore, in this context the relationship
between eNOS expression and the maintenance of the
undifferentiated state is relevant. In this regard, was observed
that around 50% of D3-eNOS cells cultured in the absence of
LIF failed to differentiate, whereas NOS inhibition by L-NMMA
maintained only 16% of cells expressing GFP under control of
the Oct4 promoter. Analysis of the gene expression and
protein immunocytochemistry corroborated these results. It is
interestingthat the protein levels did not correlate well with
mRNA levels, suggesting that pluripotency marker regulation
involves the regulation of protein levels. In this respect, roles
for caspase activation and post-translational modification of
self-renewal proteins have been recently put forward.5 It is
important to note that the effects of NO on differentiation and
the maintenance of pluripotency are dose dependent, with
more beneficial effects at lower concentrations. Early differ-
entiation markers, such as Brachyury, Gata 4, Gata6, Fgf5
and Fgf8 are considerably repressed.
The SSEA-1 surface marker of undifferentiated cells and
colonies positive for alkaline phosphatase staining also
showed that after five days of culture without LIF, several
cells remained with markedly undifferentiated activity and
morphology. Most of the cultured cells showed evidence of an
initial differentiation process, suggesting that NO could be
acting in a selective way on the total ESC population. This is in
accordance with the notion that ESCs exhibit a high degree of
heterogeneity reflected in their variegated expression of some
of the pluripotency genes, promiscuous activation of lineage-
specific genes and the fluctuating flow of differentiating cells in
cultured populations.37
The mechanisms by which NO may modulate the differ-
entiation of ESCs are a matter of debate. Studies on signal
transduction pathways activated by NO could shed light on
this issue. In fact, exposure to NO does not induce Stat3
phosphorylation in mouse or human ESCs (Supplementary
Figure 5). This finding indicates that the mechanism of action
of NO is independent of this pathway. This observation is
consistent with reports showing regulation of Nanog that is
independent from the LIF/Stat3 pathway4 and with the fact
that Nanog over-expression in conditions of LIF deprivation is
able to maintain self-renewal and increase the proliferation of
ESCs. Moreover, the NO-induced activation of c-Src and Akt
observed in ESCs (Supplementary Figure 5) is similar to our
previous findings in other cell types.21 These results are also
consistent with data reported by Anneren et al.38 and Rubbin
et al.,39 where they show that IRS-1 proteins, the PI-3K/Akt
system and c-Src family proteins are important for mESC self-
renewal. However, the mechanisms involved in the regulation
of these signalling pathways by NO need to be studied in
greater detail.
Currently, diverse mechanisms are known that control the
transition of ESC from self-renewal and the pluripotent state to
differentiation. All of them involve the dynamic and intricate
network of pluripotency and differentiation proteins, the first of
which must be switched off to go ahead with differentiation.
High amounts of NO control the mobilization and differentia-
tion of various organ-derived precursor cells, probably by
controlling the activation of promoter regions of some genes
and by enforcing epigenetic changes involved in cell-cycle
arrest and differentiation.22,40 We provide evidence for a role
of low NO in controlling stem cell self-renewal and differenti-
tion. The nature of the events triggered in this novel process at
the gene regulation level deserves further study.
Materials and Methods
Cell culture and generation of transfectants. Three embryonic stem-
cell lines were used: (i) mESC lines D3 and R1-E, obtained from the ATCC and
(ii) hESC line HS181, kindly provided by the Karolinska Institute.
The D3 and R1-E mESCs were cultured at low density in Dulbecco’s modified
Eagle’s Medium (Gibco, Carlsbad, CA, USA) supplemented with 15% fetal bovine
serum (Gibco), nonessential amino acids (1%), 2-mercaptoethanol (0.1 mM), L-glutamine
(4 mM), sodium pyruvate (1 mM), penicillin (100 IU/ml) and streptomycin (0.1 mg/ml).
The undifferentiated state was maintained by adding 1000 U/ml rLIF (Gibco) to the
culture medium. For the generation of transfectants, mESCs were electroporated at
800 mV/50mF with 30 ng of linearized p-Oct4-eGFP-pgk hygro plasmid to obtain
D3-pOct4-eGFP mESCs, and with 30 ng of circular pCDNA3.1-eNOS (provided by
Dr DJ Stewart, Department of Medicine, University of Toronto, Toronto, Ontario,
Canada) to obtain D3-eNOS mESCs. Selection was initiated 48 h following
transfection with 500mg/ml hygromicin or 400mg/ml G418, respectively. Double
transfectants (D3-pOCt4-eGFP-eNOS mESCs) were selected by the addition of the
two antibiotics together. For experiments with mESCs, cells were cultured in
colonies in the absence or presence of LIF. For treatments, increasing
concentrations of DETA-NO were added to the culture medium of cells grown in
the absence of LIF. The eNOS inhibitor L-NMMA was used at 400mg/ml.
hESCs were cultured on mitomycin C-inactivated human foreskin fibroblast
feeder cells (CRL-2429, ATCC) at 371C, 5% CO2 in Dulbecco’s modified Eagle’s
Medium/KO supplemented with 20% knock-out serum replacement (Gibco Invitrogen
Corporation, Carlsbad, CA, USA), 2 mM L-glutamine (Gibco Invitrogen corporation),
0.1 mM 2-mercaptoethanol (Gibco Invitrogen Corporation), 1% nonessential amino
acids (Gibco Invitrogen Corporation) and 100 U/ml per 100 mg/ml penicillin/streptomycin
(Gibco Invitrogen Corporation). Cells were subcultured every 10 days by mechanical
splitting. For the experimental conditions described here, hESCs were cultured on
Matrigel-coated tissue culture plates (BD Biosciences, San Jose, CA, USA) in the
previous medium in the absence or presence of 8 ng/ml bFGF and 2mM DETA-NO.
RNA isolation and cDNA synthesis. Collected ESCs were washed with
PBS 1 and then resuspended in Easy Blue reagent (Intron Biotechnology, Seoul,
Korea) for RNA isolation. Following phenol/chloroform extraction, total RNA was preci-
pitated in 2-propanol, washed with ethanol, suspended in nuclease-free water and stored
at201C until being used for cDNA synthesis. The absorbance of the total RNA for
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each sample was evaluated at 260 and 280 nm to determine its concentration and
purity using a NanoDrop ND-1000 Spectrophotometer (Nanodrop, Willmington, DE,
USA). Then, reverse transcription was performed with 1mg of RNA using 5 U/ml
MMLV Reverse Transcriptase (Promega, Madison, WI, USA) and 12.5mg/ml random
primers (Promega) in a volume of 25ml and incubated for 1 h at 371C.
Quantification of gene expression by RT-PCR and telomerase
activity. The primer sets are listed in Supplementary Table 1. The cDNA obtained was
diluted 1 : 10 and then used as a template for qRT-PCR using PerfeCTa SYBR GREEN
Super Mix, Low ROX (Quanta Bioscience, Gaithersburg, MD, USA). Briefly, for a 20ml
reaction: 10ml of SYBR Green master mix 2X, 0.2mM primers, 1ml of diluted cDNA and
water. Data collection was at 601C, 1 min with the Applied Biosystems 7500 RT-PCR
System (Applied Biosystems, Foster City, CA, USA). All the samples were normalized to
the housekeeping gene b-actin, and all the data were analyzed with the DDCT method.
Telomerase activity was determined using the Telo TAGGG telomerase PCR
ELISAPLUS Kit according to the manufacturer’s instructions (Roche, Mannheim, Germany).
Flow cytometry and cell sorting. D3, D3-pOct4-eGFP and D3-pOCt4-
eGFP-eNOS mESCs were cultured for 7 days in the presence or in the absence of
LIF and in the absence of LIF supplemented with 2 mM DETA-NO or in the absence
of LIF plus 400mM L-NMMA for D3-pOct4-eGFP-eNOS mESCs. Flow cytometry
and cell sorting were performed using a FACSscan (BD Biosciences) and the data
were analyzed using CELLQUEST software.
DNA fragmentation. DNA fragmentation was detected by an ELISA method
according to the manufacturer’s instructions (Roche).
Alkaline phosphatase assay. Cells were cultured at a density of 3 103
cells in 60 mm dishes for 5 days. Cells were fixed with 4% paraformaldehyde for
2 min at room temperature. Staining for alkaline phosphatase was performed using
SIGMA FAST Alkaline Phosphatase Substrate Tablets Set (Sigma, St. Louis, MO,
USA) following protocols provided by the manufacturer.
Immunofluorescence. mESCs were grown on Lab-Tek chamber slides
(Nunc, Rochester, NY, USA), fixed with 4% paraformaldehyde and stained with mouse
anti-Oct4 (1 : 200) (Chemicon, Charlottesville, VA, USA) and mouse anti-SSEA-1 (1 : 100)
(Chemicon) primary monoclonal antibodies. hESCs were grown on Lab-Tek chamber
slides coated with matrigel, fixed with 4% paraformaldehyde and stained with human
anti-Oct4 (1 : 100) (Chemicon) and human anti-SSEA-4 (1 : 100) (Chemicon) primary
monoclonal antibodies. Slides were incubated with anti-mouse immunoglobulin M (IgM)
and anti-rabbit immunoglobulin G (IgG). Affinity-purified rhodamine red-conjugated anti-
mouse IgM and fluorescein-conjugated anti-rabbit IgG (Jackson Immuno Research
Laboratories, West Grove, CA, USA) were directed against the primary antibodies. Cells
were counter-stained with 300 nM DAPI. Slides and cover slips were mounted in a solution
containing 4% propyl-gallacte (P/V), 90% glycerol (V/V) and 10% PBS (V/V) and viewed
with a Leica AF6000 microscope equipped with a fluorescent attachment or a Leica TCS
SP5 confocal microscope. Images were processed with Metamorph.
Western blotting and immunoprecipitation. Total protein was extracted
in RIPA buffer supplemented with protease and phosphatase inhibitors (Sigma).
Protein concentrations were determined by BIO-RAD protein assay. Protein (20mg)
was separated by 10% SDS-PAGE and transferred to a PVDF membrane (Amersham,
GE Healthcare Europe GmbH, Barcelona, Spain). The membrane was incubated
with primary monoclonal anti-mouse Oct4 (1 : 1000) (Bd Transduction Laboratories,
San Jose, CA, USA), monoclonal anti-mouse c-Src (clone 327) (1 : 2000) (Chemicon),
monoclonal anti-human Sox2 (1 : 1000) (R&D Systems), polyclonal anti-mouse Nanog
(1 : 2000) (Bethyl Laboratories, Montgomery, TX, USA), monoclonal anti-mouse b-actin
(1 : 5000) (Sigma), polyclonal anti-human Stat3 (1 : 2000) (Upstate), monoclonal anti-
mouse cleaved caspase-3 (Asp175) (1 : 1000) (Cell Signaling), polyclonal anti-mouse
PARP (1 : 1000) (Cell Signaling), monoclonal anti-mouse pStat3 (Tyr 705) (1 : 1000)
(Upstate), polyclonal anti-mouse Akt (1 : 2000) (Cell Signaling), polyclonal anti-
mouse pAkt (Ser 473) (1 : 1000) (Cell Signalling), polyclonal anti-mouse pErk 1/2
(Thr202/Tyr204) (Cell Signalling) and polyclonal anti-human p-Src (Tyr 416) (1 : 1000)
(Cell Signalling). This incubation was followed by incubation with their respective
secondary peroxidase-conjugated antibodies. Immunoreactive bands were detected
by chemiluminescence reagents (Millipore, Billerica, MA, USA). For post-translational
modification studies, the proteins were immunoprecipitated as described previously.21
Briefly, after treatment, mESCs and hESCs were lyzed in RIPA buffer (Sigma)
supplemented with protease (Sigma) and phosphatase (Sigma) inhibitors for
15 min at 41C. Then, lysates were centrifuged to remove debris, incubated with
primary antibodies overnight at 41C and finally incubated with Protein G Sepharose
for 4 h at 41C. The beads were washed three times in lysis buffer and incubated with
SDS-PAGE sample buffer for 10 min at 951C. The sample buffer was carefully
removed and run on a 10% SDS-PAGE gel and subsequently analyzed utilizing the
phospho-specific antibodies pStat3 (Tyr 705), p-c-Src (Tyr 416), pErk 1/2 (Thr202/
Tyr204) and pAkt (Ser 473).
Statistical analyses. All data are the mean± S.E.M. of at least three
independent experiments, except for the western blotting results, in which case a
representative experiment is depicted in the figures. Comparisons between values
were analyzed using one-way analysis of variance; Pr0.05 was considered
statistically significant.
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